Trials / Conditions / Glaucoma, Open-Angle

Glaucoma, Open-Angle

203 registered clinical trials studyying Glaucoma, Open-Angle — 29 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients NCT04007276	Tulane University	Phase 4
Not Yet Recruiting	Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement NCT07486323	The Hong Kong Polytechnic University	N/A
Not Yet Recruiting	DSLT in Normal Tension Glaucoma (NTG) Asian Eyes NCT07300852	Ngoc Nguyen Inc.	N/A
Enrolling By Invitation	Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty NCT07073937	University of Utah	—
Recruiting	SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients NCT07152132	Minia University	N/A
Recruiting	Electrical Stimulation for Vision Neuroenhancement in Glaucoma NCT06685211	Stanford University	N/A
Recruiting	Transscleral Selective Laser Trabeculoplasty Project NCT06833060	Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)	N/A
Recruiting	Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension NCT06964191	PolyActiva Pty Ltd	Phase 2
Not Yet Recruiting	A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtra NCT06809647	PLU Ophthalmic	N/A
Completed	24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring NCT06689696	Smartlens, Inc.	—
Recruiting	A Trial of Hydrus Microstent Versus Goniotomy NCT06289491	Massachusetts Eye and Ear Infirmary	N/A
Recruiting	Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone NCT06848946	Glaukos Corporation	Phase 4
Recruiting	Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma NCT07063537	Nova Scotia Health Authority	N/A
Recruiting	Optic Nerve Head Strain as Biomarker for Glaucoma NCT06240312	Johns Hopkins University	N/A
Terminated	How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? NCT06369077	CT Glaucoma Associates	Phase 4
Recruiting	Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial NCT05405868	University College, London	Phase 3
Recruiting	Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma NCT05710198	Omikron Italia S.r.l.	Phase 3
Active Not Recruiting	Exercise Training in Patients With Glaucoma NCT06058598	Henner Hanssen	N/A
Unknown	Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas NCT06154330	Davinci LTD	—
Recruiting	Evaluation of Phacogoniotomy in Medically-controlled POAG NCT06201455	Sun Yat-sen University	N/A
Recruiting	Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone NCT06066645	Glaukos Corporation	Phase 3
Recruiting	Feasibility Clinical Evaluation of the Calibreye System NCT05885022	Myra Vision Inc.	N/A
Unknown	MicroPulse TLT - UK Study NCT05593354	Imperial College Healthcare NHS Trust	—
Active Not Recruiting	Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hy NCT05949242	Ridge Eye Care	N/A
Recruiting	Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery NCT05625958	Ciliatech	N/A
Completed	Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety NCT05857267	Laboratorios Poen	Phase 4
Recruiting	Electrical Stimulation for the Treatment of Glaucoma NCT05626491	Stanford University	N/A
Recruiting	Electrical Stimulation for the Treatment of Optic Neuropathies NCT05626426	Stanford University	N/A
Active Not Recruiting	Use of Methazolamide to Lower Intraocular Pressure NCT05498103	University of Colorado, Denver	Phase 4
Unknown	Exercise Intervention in Primary Open-angle Glaucoma NCT05704777	Universidad de Granada	N/A
Recruiting	Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract NCT05624398	Vold Vision P.L.L.C	N/A
Completed	A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure NCT05451329	VivaVision Biotech, Inc	Phase 2
Recruiting	Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in th NCT05401357	Amneal Pharmaceuticals, LLC	Phase 3
Recruiting	GATT Versus Canaloplasty (GVC) NCT05366647	Medical University of Bialystok	N/A
Active Not Recruiting	Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narro NCT05236439	Ciliatech	N/A
Completed	Evaluating Home Testing Devices for the Management of Glaucoma NCT05325996	Wills Eye	N/A
Unknown	Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension NCT05277870	University of Washington	N/A
Terminated	Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) NCT04658095	Sight Sciences, Inc.	N/A
Completed	Citicoline & Antioxidants in Glaucoma NCT06355765	University of Naples	—
Enrolling By Invitation	Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial NCT05159960	Vastra Gotaland Region	N/A
Completed	Social History and Glaucoma Progression NCT06434155	Assiut University	—
Unknown	Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma NCT05159817	Ciliatech	—
Active Not Recruiting	Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor NCT05127551	Glaukos Corporation	N/A
Unknown	XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma NCT05130554	Zhongshan Ophthalmic Center, Sun Yat-sen University	N/A
Completed	Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients NCT05181046	Nanodropper, Inc.	N/A
Terminated	Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® fo NCT04702789	Laboratorios Sophia S.A de C.V.	Phase 4
Withdrawn	Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial NCT05043831	BelkinVision	N/A
Completed	Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The NCT04890106	Mankind Pharma Limited	Phase 3
Recruiting	Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical NCT05039684	Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA	—
Completed	A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System NCT05044793	Sight Sciences, Inc.	—
Completed	An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical Syste NCT04872348	Sight Sciences, Inc.	—
Completed	To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glauco NCT04944290	Padagis LLC	Phase 3
Completed	Impact of Self-tonometry on Glaucoma Treatment Decision. NCT04888156	St. Erik Eye Hospital	—
Withdrawn	Augmented Macular Pigment-containing Nutraceutical and Central Visual Function NCT04676126	University of the Incarnate Word	Phase 4
Terminated	Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) NCT04770324	Ciliatech	N/A
Completed	Performance of the Travoprost Intraocular Implant NCT06582732	Glaukos Corporation	Phase 2
Completed	Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma NCT04619654	Vold Vision P.L.L.C	N/A
Unknown	Glaucoma and Sleep Quality NCT04703959	University Hospital, Grenoble	—
Terminated	A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma NCT04616573	Sight Sciences, Inc.	N/A
Unknown	Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C NCT04750447	Prism Eye Institute	—
Completed	Keratometric Change After XEN, Trabeculectomy and Tube Shunts NCT04602923	Centre hospitalier de l'Université de Montréal (CHUM)	N/A
Completed	Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma NCT04632329	Equinox	N/A
Active Not Recruiting	iStent Inject New Enrollment Post-Approval Study NCT04624698	Glaukos Corporation	N/A
Unknown	Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle NCT04920227	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Unknown	The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angl NCT04912362	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	Glaucoma Surgery Using the ViaLase Laser System NCT04949802	Vialase, Inc.	N/A
Terminated	A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma NCT04465630	Sight Sciences, Inc.	N/A
Unknown	24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucom NCT05299593	Fondazione G.B. Bietti, IRCCS	Phase 4
Unknown	Micropulsed Laser Trabeculoplasty Using Different Parameters NCT04900142	University of Modena and Reggio Emilia	N/A
Unknown	iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study NCT04624685	Glaukos Corporation	—
Unknown	Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation NCT04234932	University of the Incarnate Word	EARLY_Phase 1
Unknown	Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affecte NCT04038034	VISUfarma SpA	N/A
Completed	Nailfold Capillary Blood Flow With Latanoprost Bunod NCT03949244	Icahn School of Medicine at Mount Sinai	Phase 4
Completed	MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool NCT03996200	iSTAR Medical	N/A
Completed	To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glauco NCT04024072	Padagis LLC	Phase 3
Completed	Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) NCT03797469	Columbia University	N/A
Terminated	Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Applic NCT03875911	University of California, Los Angeles	Phase 4
Terminated	Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma NCT03736655	Ciliatech	N/A
Enrolling By Invitation	INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predic NCT04381611	Dr. Kaweh Mansouri	—
Active Not Recruiting	Optimal Treatment Protocol for Selective Laser Trabeculoplasty NCT03798223	Vastra Gotaland Region	N/A
Completed	visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry NCT03804684	Wills Eye	N/A
Completed	Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hyp NCT03808688	Aerie Pharmaceuticals	Phase 4
Completed	Clinical Study Comparing Two Models of a Travoprost Intraocular Implant NCT03868124	Glaukos Corporation	Phase 3
Completed	Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open NCT03657797	Nicox Ophthalmics, Inc.	Phase 2
Completed	Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Soluti NCT03519386	Glaukos Corporation	Phase 3
Completed	Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Su NCT03325751	Insel Gruppe AG, University Hospital Bern	—
Terminated	Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union NCT03634319	MicroOptx	N/A
Completed	MINIject Glaucoma Implant in European Patients NCT03624361	iSTAR Medical	N/A
Completed	Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure NCT03689088	Sensimed AG	N/A
Completed	Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra NCT03255785	Glaukos Corporation	N/A
Completed	Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification NCT04452279	Vance Thompson Vision	N/A
Completed	Investigation of the iStent Inject® Devices in Open-Angle Glaucoma NCT03624699	Dr. Kaweh Mansouri	N/A
Completed	H-1337 Ophthalmic Solution Phase 1/2 NCT03452033	Allysta Pharmaceutical	Phase 1 / Phase 2
Completed	Phaco-UCP Versus Phaco Alone for OAG and Cataract NCT04430647	Ameera Gamal Abdelhameed	N/A
Terminated	IOP Monitoring After Trabeculectomy Using iCare Home NCT03445806	St. Erik Eye Hospital	—
Completed	A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent NCT03106181	Royal Victoria Eye and Ear Hospital	N/A
Withdrawn	Trabeculectomy Versus 2-iStent and Prostaglandin Study NCT03274323	Johns Hopkins University	N/A
Completed	Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refrac NCT04297930	National University Hospital, Singapore	—
Recruiting	Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects NCT03870230	Medical University of Vienna	N/A
Completed	Absorption and Safety of Topical Timolol to Treat Chronic Wounds NCT04903366	VA Northern California Health Care System	—
Completed	Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach NCT04406467	Johns Hopkins University	—
Completed	A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of I NCT03293992	Hoffmann-La Roche	Phase 1
Completed	European Nutrition in Glaucoma Management Trial NCT04460365	Centre for Eye Research Ireland	N/A
Unknown	The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI NCT03369886	Pusan National University Hospital	N/A
Terminated	A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra NCT03255798	Glaukos Corporation	N/A
Completed	Lamina Cribrosa Depth Change With Change in Eye Pressure NCT03267849	Johns Hopkins University	N/A
Completed	Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma NCT03187418	Centre hospitalier de l'Université de Montréal (CHUM)	N/A
Completed	Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade NCT04202562	Hospital San Carlos, Madrid	N/A
Completed	Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade NCT04476810	Ahmed Al Habash	N/A
Completed	Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing NCT03612817	Aristotle University Of Thessaloniki	Phase 4
Completed	Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension NCT02863705	Allergan	Phase 4
Completed	The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure NCT02754570	University of Colorado, Denver	N/A
Completed	A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on NCT03204487	Ordination Dr. Hommer	Phase 4
Completed	Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution NCT02754596	Glaukos Corporation	Phase 2
Completed	Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension NCT02571712	Allergan	Phase 4
Completed	Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open- NCT02507687	AbbVie	Phase 3
Unknown	Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma NCT02379208	Turku University Hospital	—
Unknown	Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent NCT03151577	Swiss Vision Network	N/A
Completed	Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Oc NCT02247804	Allergan	Phase 3
Completed	Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hyper NCT02250651	Allergan	Phase 3
Completed	Scleral Response to Intraocular Pressure (IOP) NCT03267862	Johns Hopkins University	—
Unknown	Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glauco NCT02679482	Fundación Oftalmológica Nacional	—
Completed	Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma NCT02338362	University Health Network, Toronto	Phase 4
Completed	The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma NCT03373942	Emine Deniz Egrilmez	—
Completed	Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surg NCT02114073	Mashhad University of Medical Sciences	Phase 2
Completed	Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases NCT04215575	Ain Shams University	N/A
Completed	Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma NCT03966560	Afyon Kocatepe University Hospital	Phase 4
Completed	The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle NCT02388360	Maisonneuve-Rosemont Hospital	Phase 4
Completed	The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study NCT01857440	Ohio State University	—
Completed	An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Sw NCT01735214	Allergan	—
Completed	Silicone Tube for the Surgical Treatment of Glaucoma NCT03558126	yin ying zhao	N/A
Completed	AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma NCT02036541	AqueSys, Inc.	N/A
Completed	AqueSys Microfistula Implant in Refractory Glaucoma NCT01640756	AqueSys, Inc.	Phase 3
Completed	A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocula NCT01646151	Allergan	—
Completed	A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) NCT01589510	Allergan	—
Completed	A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension NCT01594970	Allergan	Phase 4
Completed	Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) NCT01540370	Allergan	—
Completed	The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases NCT04214847	Ain Shams University	N/A
Completed	Punch Trabeculectomy Versus Classic Trabeculectomy NCT04651231	Ain Shams University	N/A
Completed	Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) NCT01547598	Allergan	Phase 4
Unknown	Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost NCT01430923	Aurolab	N/A
Completed	Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypert NCT01489670	Allergan	—
Terminated	Glaucoma Eye Drop Instillation: Impact of Education NCT01416415	Northwestern University	N/A
Completed	Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma NCT02376114	Maisonneuve-Rosemont Hospital	Phase 2
Completed	A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension NCT02020512	Allergan	Phase 4
Completed	Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patient NCT01291108	Allergan	Phase 2
Completed	Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hyper NCT01241240	Allergan	Phase 3
Completed	SOLX Gold Shunt for Refractory Glaucoma NCT01282346	SOLX, Inc.	N/A
Completed	Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hyper NCT01217606	Allergan	Phase 3
Completed	Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hy NCT01253902	Allergan	Phase 4
Completed	Assessment of Effectiveness Ex-Press Surgery Modification NCT03800589	Military Institute od Medicine National Research Institute	N/A
Completed	A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma ( NCT01628614	Allergan	—
Completed	Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution NCT01215786	Allergan	Phase 1
Unknown	Saccadic Eye Movements Are Impaired In Glaucoma NCT01254058	Unity Health Toronto	—
Completed	A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension NCT02003534	Allergan	Phase 4
Completed	Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Gl NCT01243567	Allergan	Phase 4
Completed	GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive NCT01628601	Allergan	—
Completed	A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension NCT02061683	Allergan	Phase 4
Completed	Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) NCT01628588	Allergan	—
Completed	A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) NCT01632423	Allergan	—
Completed	A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 NCT00934089	Pfizer	Phase 2
Completed	Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalm NCT01001195	Allergan	Phase 2
Completed	Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea NCT01976624	Allergan	—
Completed	A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years NCT01629407	Allergan	—
Completed	Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (PO NCT00913029	Glaukos Corporation	Phase 4
Completed	A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma NCT00911924	Glaukos Corporation	Phase 4
Completed	A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive NCT01637246	Allergan	—
Completed	Safety and Efficacy of Combigan® Ophthalmic Solution in Korea NCT01987752	Allergan	—
Completed	Safety and Efficacy of a Glaucoma Drug Delivery System NCT00824720	Vistakon Pharmaceuticals	Phase 2
Completed	Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension NCT00804648	Vistakon Pharmaceuticals	Phase 4
Completed	Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xal NCT00801437	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy NCT00693485	Allergan	Phase 2
Completed	Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hyperten NCT00753168	Othera Pharmaceuticals	Phase 1 / Phase 2
Completed	Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada NCT00334750	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression NCT00981422	University of Parma	—
Completed	Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® NCT00486252	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Intraocular Pressure With Loteprednol and Dexamethasone NCT00781300	Federal University of São Paulo	Phase 4
Unknown	Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition NCT00306657	Kantonsspital Aarau	N/A
Terminated	Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Fl NCT00410267	University of Pittsburgh	—
Completed	Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments. NCT00347191	Aston University	—
Completed	A Long-term Safety Study of Once-daily Travatan NCT00051168	Alcon Research	Phase 3
Recruiting	Dresden Glaucoma and Treatment Study (DGTS) NCT02959242	Technische Universität Dresden	—
Suspended	SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma NCT00382395	SOLX, Inc.	Phase 3
Completed	A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W NCT00140049	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects Wit NCT00159653	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hype NCT00219596	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	SOLX Titanium Sapphire Laser for Trabeculoplasty NCT00145535	SOLX, Inc.	Phase 3
Completed	A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Pa NCT00647101	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therap NCT00311389	Alcon Research	Phase 3
Completed	A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-an NCT00051194	Alcon Research	Phase 2
Completed	Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatopro NCT00487214	Allergan	—
Completed	A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension NCT00150267	Pfizer	Phase 3
Completed	Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertens NCT00140062	Pfizer	Phase 4
Completed	A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Gl NCT00051142	Alcon Research	Phase 3
Completed	A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or NCT00051155	Alcon Research	Phase 3
Completed	Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes NCT00707226	Medical University of Vienna	—
Completed	Treatment of Failing Blebs With Ranibizumab NCT00570726	The New York Eye & Ear Infirmary	Phase 1
Completed	A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Gla NCT00991822	Medical University of Vienna	Phase 2 / Phase 3
Completed	Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma NCT00317577	Chicago Center for Vision Research	Phase 2
Completed	Pigment Dispersion Syndrome With and Without Glaucoma NCT00001152	National Eye Institute (NEI)	—
Withdrawn	Corneal Versus Conjunctival Delivery Using a Delivery Device NCT00143429	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 2
Completed	Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon NCT00470964	Goldschleger Eye Institute	N/A
Withdrawn	Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device NCT00283764	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3